This is an interesting approach to the aging problem:
The study, led by Assistant Professor Corina Amor Vegas, utilized a technique known as CAR (chimeric antigen receptor) T cell therapy.
This “living” drug is already known for its effectiveness in treating certain blood cancers, having received FDA approval in 2017.
However, Amor Vegas and her team are the first to demonstrate its potential beyond cancer treatment, showing its remarkable ability to rejuvenate and slow down aging in mice.
The results observed in mice were significant. They displayed a reduction in body weight, enhanced metabolism and glucose tolerance, and increased physical activity, all without any tissue damage or toxicity.
“If we give it to aged mice, they rejuvenate. If we give it to young mice, they age slower. No other therapy right now can do this,” said Amor Vegas.
Note that the FDA approved this in 2017. This could significantly reduce the time to market for use as an anti-aging drug. And it would seem that doctors could start prescribing it off label immediately.
I like living in the future.